NEWS FLASH
In this section, you will find the latest relevant developments of the COVID-19 pandemic.
Artificial Intelligence-Powered Apps Helped Protect Businesses from COVID-19 Risks
A new study undertaken by Anglia Ruskin University (ARU) and published in the journal Information Systems Frontiers has found that Artificial Intelligence (AI) apps helped….
Vaccinated Population less Likely to Develop Long COVID
A new study shows that receiving two doses of a coronavirus vaccine before a SARS-CoV-2 infection is associated with reduced long COVID symptoms after 12 weeks.
ILO and UNDP Joint Statement for a Human-Centred Recovery from COVID-19
International Labour Organization (ILO) and United Nations Development Program (UNDP) joint statement for a human-centred approach for recovery from COVID-19 crisis and accelerated action on jobs, informality and social protection.
According to WHO New COVID-19 Cases and Deaths Are Dropping for the Third Week in a Role
The number of new coronavirus cases around the world fell by 21% in the last week, marking the third consecutive week that COVID-19 cases have dropped, said the World Health Organization.
New Study Suggests that Pandemic-Related Stress Can Impact Uninfected People’s Brain Health
New research published in Brain, Behavior and Immunity indicates that even for individuals who have steered clear of becoming infected with SARS-CoV-2, the societal and lifestyle disruptions during the COVID-19…
Review Shows that Long COVID is a Global Issue for Patients and Healthcare Systems
After reviewing the effects of COVID-19 on patients, a study led by Oxford University shows that the current understanding of long COVID and options to treat it, is emerging as a major long-term issue for global healthcare systems.
Pre-Infection Vitamin D Deficiency Is Associated with Increased Disease Severity and Mortality among Hospitalized COVID-19 Patients
A study published in Israel show a correlation between vitamin D deficiency and COVID-19 severity and mortality.
Pfizer Vaccine for Children under 5 Years Old may be Available in U.S. by the End of February
In the U.S. the vaccine manufactures Pfizer and its partner, BioNTech, are expected to submit to the Food and Drug Administration
The Pan American Health Organization (PAHO) warns about neglect or delayed treatment for tropical Diseases in Americas due to COVID-19 Pandemic
The Pan American Health Organization (PAHO) is urging governments to provide comprehensive and….
Child masking associated with reduced COVID-19 related child care closures
A new Yale study found that child care programs in the U. S. that practiced child masking early in the COVID-19 pandemic (May-June 2020)
Experts Wary on Variant Wave Reaching the Peak in Europe
The surge in coronavirus cases caused by the Omicron variant seems to have peaked in some parts of Europe.
Other Diseases may also Benefit from the Technological Advancements Achieved when Developing COVID-19 Vaccines
Since the beginning of the COVID-19 pandemic and the race for finding viable vaccines the development of mRNA-based technology represent an
‘Flurona’: Israel records its first case of patient with COVID-19 and flu at same time
Bharat Biotech Gets Approval to Test Nasal COVID-19 Shot as Booster
According to a New Global Study Tough Mask Mandates Linked to Fewer COVID-19 Deaths
According to a large international study stricter mask mandates are linked with a reduction in COVID-19 deaths.
Alcohol Consumption During the COVID-19 Pandemic Projected to Cause More Liver Disease and Deaths
Alcohol sales and consumption increased since the start of the COVID-19 pandemic, but the effect of the increase in consumption….
Long COVID: 3 in 10 COVID-19 Patients Not Fully Recovered After 1 year
A recent study found that around 30 percent of individuals hospitalized with acute COVID-19 may continue to experience long COVID symptoms….
U.S. Authorized the First Pill to Treat COVID-19 Developed by Pfizer
In the U.S. the Food and Drug Administration (FDA) agency authorized the first pill to treat COVID-19.
The regional health agency for the Americas, PAHO, alert to the risks of building resistant bacteria due to the misuse of antibiotics during the pandemic
The Pan American Health Organization (PAHO) warned about the overuse….
According to a new Study, chronic loss of smell from COVID-19 is a growing public health concern
A new study from JAMA Otolaryngology – Head & Neck Surgery, found that at least 1 in 10 people that experience loss of smell as a result of COVID-19….
Omicron variant may increase risk of SARS-CoV-2 reinfection
A South African study has found high rates of reinfection among those with previous confirmed SARS-CoV-2 infections since the beginning of November.
Time of day matters in antibody response to COVID-19 vaccine
An observational study finds that antibody levels are higher when healthcare workers received the SARS-CoV-2 vaccine in the afternoon.
UNDP launches a report on the impact of Income Support Programs (ISPs) and COVID-19 in Developing Countries
The United Nations Development Program (UNDP) published a study evaluating….
Most countries of the Americas to reach COVID-19 vaccination target by end of year
The Pan American Health Organization (PAHO) said that Latin America and….
G20 set to commit to cutting period to develop vaccines in pandemic
Leaders of the world’s 20 largest economies are set to commit to supporting efforts to shorten to 100….
A new report on biodiversity and pandemics from United Nations Environmental Program (UNEP) warns that pandemics may be more frequent in the future and offers policy options to reduce risks
According to many studies more pandemics are likely to happen….
In U.S., More Screen Time and Less Physical Activity During Pandemic May Affect Kids and Teens Mental Health
With the closure of schools and cancellation of youth activities (such as sports….
Study Reveals Why Some People Get COVID Toe Condition
Scientists believe they can explain why some people infected by COVID-19 develop lesions on their toes and even fingers.
Depression Rates in the U.S. More Than Tripled During the Pandemic
A new study examining the COVID-19 pandemic affects on mental health found that not only has the pandemic caused….
Suicides Among Japanese Children at Record High During Pandemic
According to Japaneses authorities child suicides in Japan are at he highest level they have been in more than four decades.
According to the Pan American Health Organization (PAHO) Countries Should Prioritize Pregnant, Breastfeeding Women for COVID-19 Shots
Countries in the Americas should prioritize…
More Sleep Boosts Teens’ Ability to Cope with the Pandemic
According to a new research, encouraging better sleeping habits could help reduce teens’ stress and improve their ability to cope in times of crisis.
Lack of Outdoor Time Likely Impacted Quality of Life During Pandemic
According to a survey published by the Journal of Sleep Research roughly half of adults worldwide…
Pfizer Begins Study of Oral Drug for Prevention of COVID-19
Pfizer announced that it has started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection.
New study finds that domestic control of COVID-19 takes priority over international travel bans
According to a paper written by urban and environmental economics expert, taming domestic transmission of….
Pollution from wildfires may increase COVID-19 risk in affected regions
The microscopic particle PM2.5, generated by the wildfires smoke can increase the risk for COVID-19….
Study Suggests that Future Pandemic Response Needs to Consider Cultural Context
A study on COVID-19 response analyzed data from 107 nations, focusing on the first 91 days of the pandemic.
U.S. States with Stronger Controls Register Fewer Deaths Due to COVID-19
A study has found a clear correlation between stronger state interventions to control the spread of COVID-19 and fewer deaths from…
US life expectancy in 2020 saw biggest drop since WWII
According to the Center for Disease Control and Prevention (CDC), U.S. life expectancy fell by a year and a half in 2020, the largest one-year decline since World War II…
Return to normal life after COVID may not occur until 2023 according to French scientist
A return to normal life following the COVID-19 virus outbreak may not occur until 2022 or even 2023, said professor Jean-Francois Delfraissy, who advises the French government…
Vaccine antibody levels start to wane around 2 or 3 months after vaccination
According to new data from UCL’s Virus Watch study, the total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% in 10 weeks…
More than 1 in 10 COVID-19 patients report memory loss
A study by JAMA Network Open found that more than one in ten people with COVID-19 report memory and concentration problems up to eight months after the infection…
A new study suggests that early COVID-19 symptoms differ among age groups
According to a new study, symptoms for early COVID-19 infection differ among age groups and between gender. These differences are most notable between younger age groups (16-59 years) compared to older age groups (60-80 years)…
COVID-19 pandemic leads to major backsliding on childhood vaccination, new WHO and UNICEF data shows
According to official data published by WHO and UNICEF, 23 million children missed out on basic vaccines through routine immunization services in 2020 – 3.7 million more than 2019
Delta COVID variant now dominant strain worldwide, U.S. deaths surge
The Delta variant of COVID-19 is now the dominant strain worldwide, accompanied by a surge around 26% of deaths in the United States almost entirely among unvaccinated people, U.S. officials said on Friday.
High respiratory efforts in COVID-19 patients could result in self-inflicted lung injury
The impact of high breathing efforts on the lungs of patients suffering from acute respiratory failure due to COVID-19 has been investigated by researchers at the University of Warwick, who assessed the likelihood of resulting lung injury.
COVID-19 shutdowns reveal racial disparities in exposure to air pollution
A new study of COVID-19 shutdowns in the United States reveals pronounced disparities in air pollution. Disenfranchised neighborhoods with minority populations are exposed to more harmful air pollutants compared to the wealthier white communities.
COVID recovery plans will produce record emissions according to International Energy Agency (IEA)
Pandemic recovery plans will come at a substantial environmental cost with carbon emissions estimated to hit an all-time high by 2023, according to a report from the International Energy Agency (IEA) published on Tuesday.
Infant risk for COVID-19 directly related to spread in community
A new study published by the journal Pediatrics shows that the risk for COVID-19 among infants and young children depends on the level of virus spread in the local community.
A new study suggests COVID-19 can have long-term effects on heart rate
Roughly one in six people contracted with COVID-19 experiences irregular heartbeats for more than four months after developing initial symptoms, a study published by the JAMA Network Open found
JPMorgan finds five emerging economies among the most vulnerable to the Delta variant
An analysis lead by JPMorgan found that economies from emerging markets are among the most vulnerable to the COVID-19 Delta variant, mostly due to low vaccination rates.
The SARS-CoV-2 infection is more common in pets than expected
Researchers in Brazil have discovered a higher than expected incidence of SARS-CoV-2 infection among the cats and dogs of people with COVID-19. Around 50% of the animals tested positive for the virus…
According to WHO official Delta COVID variant is becoming globally dominant
The Delta variant of COVID-19, (first identified in India), has increased transmissibility and is becoming the globally dominant variant of the disease, the World Health Organization’s chief scientist said on Friday.
Engineering nanobodies as lifesavers when SARS-CoV-2 variants attack
Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants. In lab studies, researchers identified two groups of molecules that were effective against virus variants
A study suggests that vitamin D supplementation may prevent acute respiratory infection
The U.S. National Institutes of Health (NIH) said on Tuesday that it has halted a trial of convalescent blood plasma in the treatment of patients with mild-to-moderate COVID-19 symptoms as no benefits were found.
COVID Brazil variant 'may spread more easily' according to a study
The study analyses the relation between mask usage and public attitudes to evaluate the impact of those cultural differences on this element of the pandemic response.
Inside the race to find a COVID-19 treatment pill
After almost 18 months of the pandemic and despite the development of a significant number of effective COVID-19 vaccines, there is still no easy-to-administer treatment proven to be effective against COVID-19.
According to PAHO (Pan American Health Organization) New Report Points to an Increase in Hospitalizations and Deaths among Patients under 60 Years
There is a change – at global level – in the age profile of hospitalized cases, pointing to higher rates of hospitalization and clinical severity among the younger population.
Fully Vaccinated Adults 65 and Older Are 94% Less Likely to Be Hospitalized with COVID-19
In the U.S. the CDC (Center for Disease Control and Prevention) finds that mRNA (Pfizer-BioNTech and Moderna) COVID-19 vaccines reduce COVID-19-related hospitalizations among fully vaccinated (two weeks after the second dose) older adults.
Vaccine Inequity poses ‘Significant Risk’ to Global Economic Recovery According to UN report
The World Economic Situation and Prospects (WESP) mid-year report warned widening inequality is threatening global recovery.
Non-hospitalised COVID-19 Patients Have Low Risk of Having Serious Long-Term Effects
Non-hospitalised COVID-19 patients have a low risk of serious long-term effects, but they report more visits to general practitioners following infection, according to a study published in The Lancet Infectious Diseases journal.
Study shows that Israeli-made anti-COVID nasal spray reduced infection at mass gathering
An Israeli-made nasal spray appears to have contributed to a reduced COVID-19 infection rate among members of an ultra-Orthodox community, just 2 out of 83 people, who were given the spray, contracted the virus.
Pregnant women are being infected with COVID-19 at higher rates
Pregnant women and their babies get infected with the coronavirus at higher rates. After accounting for other risk factors, the COVID-19 rate in pregnant women was 70% higher than in non-pregnant adults, according to a report in the American Journal of Obstetrics & Gynecology.
According to the U.S. FDA (Food and Drug Administration), trials of retooled vaccines for variants could take months
The emergence of more contagious coronavirus variants has prompted drug developers to step up efforts to track coronavirus mutations and try to keep vaccines and treatments effective against new variants.
U.S. trials of COVID-19 blood plasma halted after no benefits found
The U.S. National Institutes of Health (NIH) said on Tuesday that it has halted a trial of convalescent blood plasma in the treatment of patients with mild-to-moderate COVID-19 symptoms as no benefits were found.
COVID Brazil variant 'may spread more easily' according to a study
Early studies suggest that the Brazilian variant, called P.1 variant, could be up to twice as transmissible as the earlier version of the virus.
New evidence on COVID-19 antibodies and vaccines indicate less effectiveness against new variants
New research at Washington University School of Medicine indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic.
COVID-19 pandemic has increased loneliness and other social issues, especially for women
Researchers found a significant increase in loneliness and a decrease in feelings of friendship during the pandemic.
Sustainable infrastructure can drive development and COVID-19 recovery: A report from the United Nations Environment Programme (UNEP)
A new report from UNEP urges governments to take a more systematic approach to sustainable infrastructure, incorporating it into their long-term development plans and ensuring human-made systems work with natural ones.
Coronavirus variants may lead to false negative results with molecular tests - FDA
The U.S. drugs regulator said on Friday genetic variants of COVID-19, including the one found in the UK, could lead to false negative results from some molecular COVID-19 tests, but the risk of the mutations affecting overall testing accuracy is low.
6 Months After Leaving the Hospital, COVID Survivors Still Face Lingering Health Issues
A large study of patients in China, showed that six months later, three-quarters were struggling with problems like fatigue, depression and diminished lung function.
WHO says starting shots in poor nations by February hinges on vaccine suppliers
The World Health Organization (WHO) on Monday doubled-down on pleas for vaccine makers to provide COVID-19 shots to its COVAX programme for poor nations, as an adviser said hopes of starting inoculations by February hinges on access to supplies.
More than half of COVID-19 health care workers at risk for mental health problems
A new study, led by University of Utah Health scientists, suggests more than half of doctors, nurses, and emergency responders involved in COVID-19 care could be at risk for one or more mental health problems, including acute traumatic stress, depression, anxiety, problematic alcohol use, and insomnia.
WHO stops short of advising proof of COVID-19 shots for travel
The World Health Organization (WHO) announced that they are not advising to introduce requirements of proof of vaccination or immunity for international travel as a condition of entry because of “critical unknowns” regarding their efficacy in reducing transmission of the SARS-CoV-2.
Food Insecurity and Climate Crisis Rise Amid COVID-19 Pandemic
The hottest year on record and a global pandemic are fuelling fast-rising food insecurity and malnutrition around the world. Almost 690 million people suffered from hunger in 2019, a figure that was projected to rise by 130 million by the end of 2020 because of the coronavirus pandemic, according to the United Nations.
France tells its citizens: Fabric masks not enough to protect from COVID-19
The French government is now recommending that people wear surgical masks in public because they offer better protection from COVID-19 transmission than fabric face coverings, Health Minister Olivier Veran said on Thursday, January 21st.
Early U.S. data indicates Black and Hispanic Americans lagging in COVID-19 vaccinations
Early data on U.S. coronavirus vaccinations released on Monday suggests that Black and Hispanic Americans received a smaller proportion of shots than their representation among healthcare workers and nursing home residents, two priority groups for COVID-19 inoculations.
Russia's Sputnik V COVID vaccine highly effective, new study shows
The preliminary results of a study published on the medical journal The Lancet, shows that the Russian vaccine Gam-COVID-Vac (also known as Sputnik V) is 91.6 % effective against symptomatic COVID-19 cases.
UK finds more coronavirus cases with 'concerning' mutations
In England, public health authorities are investigating cases of coronavirus containing ‘worrying’ new genetic changes that have been found in some regions of the UK. Being called E484K, tests are showing they have a mutation that was already seen from the South Africa variant.
Young people hospitalized with COVID-19 face substantial adverse outcomes
Researchers from Brigham and Women’s Hospital analysed records from 419 hospitals using the Premier Healthcare Database to study the clinical trajectories of 3.222 hospitalized COVID-19 patients aged 18 – 34…
Media trust correlated with COVID-19 prevention behaviors
During the pandemic, individuals’ behaviour (such as wearing a mask or practicing physical distancing) is closely correlated with the kinds of mass media outlets they trust, according to a study published in etc…
COVID-19 antibodies last at least three months; so do symptoms for many
People infected with COVID-19 develop antibodies that last for at least three months, according to two reports published in Science Immunology. This means that a properly designed vaccine “should elicit a durable antibody response that has the potential to neutralize the virus”…
Facebook will ban ads discouraging people from getting vaccines
Facebook Inc, with 2.7 billion monthly active users, will start banning ads that explicitly discourage people from getting vaccinated. Facebook’s previous rules prohibited ads containing vaccine misinformation or hoaxes identified by leading health organizations…
Sewage can reveal COVID outbreaks, UK project finds
Traces of the virus that causes COVID-19 can be successfully detected in sewage, which can help to give health officials an early warning of local outbreaks of the virus, the British government said. ..
Europe becomes THE second region to cross 250,000 deaths as THE second COVID wave hits
Europe became the second region after Latin America to surpass 250,000 deaths on Saturday, according to a Reuters tally, with record numbers of daily COVID-19 infections reported in the past two weeks.
Long COVID: Some coronavirus patients have recovered, but still aren't well
Months after recovering from their coronavirus infections, some patients continue to report headaches, exhaustion and shortness of breath. Doctors are still learning about the effects of post-COVID syndrome.
Study estimates exposure to air pollution increases COVID-19 deaths by 15% worldwide
Long-term exposure to air pollution has been linked to an increased risk of dying from COVID-19. The study, published in Cardiovascular Research on 26/10, estimated that about 15% of deaths worldwide from COVID-19 could be attributed to long-term exposure to air pollution.
Oxford COVID-19 vaccine works in all ages, trials suggest
One of the world’s leading COVID-19 experimental vaccines produces an immune response in older adults as well as the young, its developers say. The phase 2 trials have shown that people over the age of 56 – and some over 70 – produced the same sort of antibody response as younger volunteers.
ASTRAZENECA PUTS VACCINE TRIAL ON HOLD AFTER PARTICIPANT FALLS ILL
On Sept 9th, Astra Zeneca announced to put on hold the controlled clinical trials of the ‘‘AstraZeneca Oxford coronavirus vaccine’’ after the discovery of the participant who fell ill…
TEAM OF SCIENTISTS SPOT ‘UNLIKELY’ PATTERNS IN RUSSIA VACCINE DATA
A team of 26 scientists have signed an open letter questioning the reliability of the data presented in the early-stage trial results of the Russian COVID-19 vaccine…
RESEARCHERS DRAW MORE LINKS BETWEEN VAPING, SMOKING, YOUNG PEOPLE, AND CORONAVIRUS
Researchers at the University of Rochester Medical Center published papers linking a risk for COVID-19 and a history of vaping and smoking…
THE OTHER WAY THE VIRUS KILL: HUNGER
The pandemic has reinforced basic economics inequalities, but none of them is more defining than access to food. As the global economy is been deeply affected by the pandemic, the potentially life-threatening levels of food insecurity in the developing world…
An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims
The pharmaceutical company Eli Lilly announced that their experimental monoclonal antibody treatment significantly reduced levels of the coronavirus in more than 450 newly infected patients and lowered the hospitalization rates…
Silicon Valley startup Visby’s portable COVID-19 test gets FDA approval
The Silicon Valley medical equipment startup, Visby Medical, has received Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) for a portable PCR COVID-19 test kit. Traditionally, PCR testing uses a machine with the size of a large microwave…
Study links rising stress, depression in US to pandemic-related losses, media consumption
A study published by researchers at University of California, Irvine, linked increasing depression and stress to not only pandemic-related losses–such as unemployment–but also media consumption…
CORONAVIRUS: ARE MUTATIONS MAKING IT MORE INFECTIOUS?
The coronavirus that is now threatening the world is subtly different from the one that first emerged in China…
BLACK AND HISPANIC CHILDREN ARE IMPACTED MORE SEVERELY BY CORONAVIRUS, RESEARCH SHOWS
A report from the US Center for Disease Control and Prevention (CDC) released Friday found that Black and Hispanic children are more likely to be hospitalized due to coronavirus than White children, with higher case rates,…
KNOWLEDGE IS POWER: LEARNING MORE ABOUT COVID-19 CAN REDUCE YOUR PANDEMIC STRESS
A recent study surveyed more than 500 adults between 20–79 years old in the U.S. to understand whether understanding the COVID-19 pandemic makes us more or less anxious…
RUSSIA CLAIMS TO HAVE A VACCINE FOR COVID-19, BUT THIS CLAIM IS QUESTIONED BY VARIOUS EXPERTS
While numerous countries and research groups are working to produce a vaccine for Covid-19, the latest developments on the vaccine came from Russia: The Russian government claims to have stolen a march on dozens of global rivals…
GENETIC PROFILES MAY PREDICT COVID-19 RISK; NURSING HOME STAFF IN SPOTLIGHT
Genetic profiles may predict COVID-19 risk. Genetic differences affect the strength of infection and protection mechanisms, with some people having genes that predispose them to infection and others having genes that strengthen the body’s protective process.
Why pregnant women face special risks from COVID-19
Although the effect of COVID-19 on pregnancy is still not completely clear due to incomplete data, the current cautious consensus among the experts is that the viral infection in pregnant women does not negatively affect fetal development…
Signs of depression and anxiety soar among US graduate students during pandemic
A survey conducted in 9 U.S. research universities recording responses from more than 15,000 graduate students showed that more students are suffering from depression this year during the pandemic compared to last year…
COVID-19 link to type 1 diabetes probed
A study suggests a possible coronavirus link to type 1 diabetes. Cases of type 1 diabetes among children may have risen during the peak of Britain’s COVID-19 outbreak. In type 1 diabetes – also known as juvenile diabetes – insulin-producing cells in the pancreas are destroyed,…
Blood clots and lung injuries found in patients who have died of COVID-19
Post-mortem examinations of 10 patients who died of COVID-19 in a UK study showed that all patients had lung injuries, early scarring of the lungs, and kidney injuries. Nine of the ten patients also have blood clots…
Two more cases of reinfection: This time reported in Europe
Two more cases of reinfection with the coronavirus were reported in Europe on Tuesday, a day after a 33-year-old man in Hong Kong was confirmed to have been infected a second time. However, experts have reacted with caution to the new findings,…
Flu Season Could Make Coronavirus Testing Delays Even Worse
In the fall season, the ascent of flu and other seasonal respiratory diseases could further burden the previous delay in coronavirus testing in the U.S., making it more likely for the infection to spread unnoticed. Usually, doctors do not test for influenza…
BRAZIL’S CORONAVIRUS CHAOS PROVIDES A GLOBAL LABORATORY FOR THE VACCINE RACE
The last clinical phase (Phase 3) tests require thousands of people to be tested. This means that the suitable areas to conduct this kind of study should have high disease transmission, as well as institutions that work with international scientific…
OXFORD CORONAVIRUS VACCINE PRODUCES STRONG IMMUNE RESPONSE
Scientists at the Jenner Institute (Oxford University) and Oxford Vaccine Group published promising results of the Phase I/II trial of a coronavirus vaccine in The Lancet. The vaccine showed no early safety concerns and induced strong immune responses in humans.
NEW ASSAY IMPROVES DETECTION OF COVID-19 ANTIBODIES
Researchers at the University of California Santa Cruz have developed a new assay for the detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
EU LEADERS SEAL DEAL ON SPENDING AND €750BN COVID-19 RECOVERY PLANS
EU leaders have reached a historic agreement on a €750bn coronavirus pandemic recovery fund and their long-term spending plans following days of acrimonious debate at the bloc’s longest summit in nearly two decades.
African countries conduct over 8.3 mln COVID-19 tests amid rapid infection rate: Africa CDC
More than 8.3 million COVID-19 tests for COVID-19 have been conducted across countries in the Africa continent (Africa CDC). The Africa CDC director warned over rising COVID-19 test positivity rate…
COVID-19's impact on the heart: Two new studies suggest 'the plot thickening'
Two separate new studies, published in the journal JAMA Cardiology on Monday, demonstrates how COVID-19 may have a prolonged impact on heart health in those who have recovered from illness and may have caused cardiac infection in those who died.
There is no 'zero risk' in easing travel restrictions, WHO says
There is no “zero risk” strategy for countries easing international travel restrictions during the COVID-19 pandemic, and essential travel for emergencies should remain the priority, the World Health Organization (WHO) said.
APPLICATIONS OF DIGITAL TECHNOLOGY IN COVID-19 PANDEMIC PLANNING AND RESPONSE
An article published in Lancet emphasizes how digital technologies helped flatten the COVID-19 incidence curves in some countries. The integration of such technologies into policies facilitate planning, surveillance, testing, contact tracing, quarantine, and clinical management…
COVID-19 NEUTRALIZING ANTIBODIES MIGHT ONLY LAST FOR 2–3 MONTHS
A publication in Nature Medicine measured levels of neutralizing antibodies in a small number (37) of asymptomatic individuals and compared them to symptomatic individuals…
“SUPER SPREADER” EVENTS
As more data became available and economies are opening up, a lot of people started to wonder what events cause the most infection cases, which can also influence policymaking…
FIRST APPROVED VACCINE IN CHINA (BUT FOR MILITARY USE ONLY)
CanSino Biologics received authorization for human trials after clinical trials proved it was safe and showed some efficacy. China’s Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing…
WHO REVIEWING REPORT URGING NEW GUIDANCE OVER SPREAD OF CORONAVIRUS
The World Health Organization (WHO) is reviewing a report urging it to update guidance on the novel coronavirus after more than 200 scientists, in a letter to the health agency, outlined evidence the virus can spread in tiny airborne particles…
SCIENTISTS WARN OF POTENTIAL WAVE OF COVID-LINKED BRAIN DAMAGE
Scientists warned of a potential wave of coronavirus-related brain damage as new evidence suggested COVID-19 can lead to severe neurological complications, including inflammation, psychosis and delirium.
REMDESIVIR BECOMES THE FIRST COVID-19 TREATMENT APPROVED IN EUROPE
Remdesivir (brand name Veklury), a drug originally developed to treat the Ebola virus by the U.S. Pharma Gilead Sciences, becomes the first COVID-19 treatment approved in Europe with a one-year conditional marketing authorization from the European Commission…
VIRUS-TRACING APPS ARE RIFE WITH PROBLEMS. GOVERNMENTS ARE RUSHING TO FIX THEM
Virus tracing apps that many countries have quickly developed are dealing with security issues that expose users to risks like identity theft or oppressive government tracking. In some cases, the use or development of apps were abandoned.